

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 9.61511709 |
| 2 | * respiratory electron transport chain (GO:0022904) | 8.93376028 |
| 3 | * electron transport chain (GO:0022900) | 8.69967157 |
| 4 | translational elongation (GO:0006414) | 6.75183814 |
| 5 | cellular protein complex disassembly (GO:0043624) | 6.40561603 |
| 6 | viral life cycle (GO:0019058) | 6.25556899 |
| 7 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 6.11730141 |
| 8 | ribosomal large subunit biogenesis (GO:0042273) | 6.01316501 |
| 9 | translational initiation (GO:0006413) | 5.84680978 |
| 10 | ATP biosynthetic process (GO:0006754) | 5.63662971 |
| 11 | maturation of SSU-rRNA (GO:0030490) | 5.54542712 |
| 12 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 5.50888356 |
| 13 | NADH dehydrogenase complex assembly (GO:0010257) | 5.50888356 |
| 14 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 5.50888356 |
| 15 | * oxidative phosphorylation (GO:0006119) | 5.45447200 |
| 16 | protein complex biogenesis (GO:0070271) | 5.36906667 |
| 17 | protein complex disassembly (GO:0043241) | 5.34455390 |
| 18 | tricarboxylic acid cycle (GO:0006099) | 5.32818194 |
| 19 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.21451760 |
| 20 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 5.16338477 |
| 21 | macromolecular complex disassembly (GO:0032984) | 5.16121983 |
| 22 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 5.11986530 |
| 23 | chaperone-mediated protein transport (GO:0072321) | 5.09281176 |
| 24 | hydrogen ion transmembrane transport (GO:1902600) | 5.01061418 |
| 25 | protein targeting to membrane (GO:0006612) | 5.00387887 |
| 26 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.90638577 |
| 27 | inner mitochondrial membrane organization (GO:0007007) | 4.85784013 |
| 28 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 4.54461386 |
| 29 | protein neddylation (GO:0045116) | 4.49425283 |
| 30 | proton transport (GO:0015992) | 4.46038125 |
| 31 | hydrogen transport (GO:0006818) | 4.38976726 |
| 32 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.33750986 |
| 33 | ubiquinone biosynthetic process (GO:0006744) | 4.23726745 |
| 34 | quinone biosynthetic process (GO:1901663) | 4.23726745 |
| 35 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 4.21918967 |
| 36 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.13193605 |
| 37 | NADH metabolic process (GO:0006734) | 4.09665385 |
| 38 | regulation of mitochondrial translation (GO:0070129) | 4.07310120 |
| 39 | regulation of cofactor metabolic process (GO:0051193) | 4.03355730 |
| 40 | regulation of coenzyme metabolic process (GO:0051196) | 4.03355730 |
| 41 | mRNA catabolic process (GO:0006402) | 3.98846117 |
| 42 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.97967822 |
| 43 | mitochondrial transport (GO:0006839) | 3.94127412 |
| 44 | succinate metabolic process (GO:0006105) | 3.91532074 |
| 45 | * aerobic respiration (GO:0009060) | 3.85681771 |
| 46 | ubiquinone metabolic process (GO:0006743) | 3.84782427 |
| 47 | regulation of oxidative phosphorylation (GO:0002082) | 3.79656631 |
| 48 | proteasome assembly (GO:0043248) | 3.69715793 |
| 49 | respiratory chain complex IV assembly (GO:0008535) | 3.66344730 |
| 50 | establishment of protein localization to membrane (GO:0090150) | 3.60985173 |
| 51 | RNA catabolic process (GO:0006401) | 3.58328340 |
| 52 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 3.57828311 |
| 53 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 3.57828311 |
| 54 | * cellular respiration (GO:0045333) | 3.55739868 |
| 55 | protein targeting to mitochondrion (GO:0006626) | 3.53675083 |
| 56 | cellular component biogenesis (GO:0044085) | 3.53552145 |
| 57 | cytochrome complex assembly (GO:0017004) | 3.51828675 |
| 58 | GTP biosynthetic process (GO:0006183) | 3.50702747 |
| 59 | protein targeting (GO:0006605) | 3.49961942 |
| 60 | regulation of cellular respiration (GO:0043457) | 3.48255141 |
| 61 | protein localization to mitochondrion (GO:0070585) | 3.46479080 |
| 62 | establishment of protein localization to mitochondrion (GO:0072655) | 3.41980890 |
| 63 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.41930145 |
| 64 | heart process (GO:0003015) | 3.33965131 |
| 65 | heart contraction (GO:0060047) | 3.33965131 |
| 66 | cullin deneddylation (GO:0010388) | 3.33301227 |
| 67 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.30549102 |
| 68 | * generation of precursor metabolites and energy (GO:0006091) | 3.26929890 |
| 69 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.25582565 |
| 70 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.25582565 |
| 71 | actin-myosin filament sliding (GO:0033275) | 3.25027899 |
| 72 | muscle filament sliding (GO:0030049) | 3.25027899 |
| 73 | establishment of protein localization to organelle (GO:0072594) | 3.20299240 |
| 74 | branched-chain amino acid catabolic process (GO:0009083) | 3.18128061 |
| 75 | ribosomal small subunit biogenesis (GO:0042274) | 3.14571733 |
| 76 | quinone metabolic process (GO:1901661) | 3.14558563 |
| 77 | regulation of sequestering of triglyceride (GO:0010889) | 3.10430090 |
| 78 | regulation of sulfur metabolic process (GO:0042762) | 3.08570419 |
| 79 | purine ribonucleoside biosynthetic process (GO:0046129) | 3.07029047 |
| 80 | purine nucleoside biosynthetic process (GO:0042451) | 3.07029047 |
| 81 | spliceosomal complex assembly (GO:0000245) | 3.05377934 |
| 82 | protein-cofactor linkage (GO:0018065) | 3.05266545 |
| 83 | intracellular protein transmembrane import (GO:0044743) | 3.03883687 |
| 84 | cotranslational protein targeting to membrane (GO:0006613) | 3.03687711 |
| 85 | organelle disassembly (GO:1903008) | 3.02364778 |
| 86 | protein deneddylation (GO:0000338) | 3.00706100 |
| 87 | regulation of cell communication by electrical coupling (GO:0010649) | 2.98514235 |
| 88 | protein localization to membrane (GO:0072657) | 2.97938523 |
| 89 | protein targeting to ER (GO:0045047) | 2.97247016 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.97017378 |
| 91 | ribonucleoside monophosphate biosynthetic process (GO:0009156) | 2.96967264 |
| 92 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.96722154 |
| 93 | aldehyde catabolic process (GO:0046185) | 2.96435145 |
| 94 | dopamine transport (GO:0015872) | 2.94914028 |
| 95 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.94848486 |
| 96 | viral transcription (GO:0019083) | 2.94518270 |
| 97 | protein localization to endoplasmic reticulum (GO:0070972) | 2.91152732 |
| 98 | translational termination (GO:0006415) | 2.87271498 |
| 99 | ribosomal small subunit assembly (GO:0000028) | 2.87146170 |
| 100 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.86898352 |
| 101 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.84595789 |
| 102 | translation (GO:0006412) | 2.83048950 |
| 103 | establishment of integrated proviral latency (GO:0075713) | 2.80250807 |
| 104 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.79438455 |
| 105 | UTP biosynthetic process (GO:0006228) | 2.79302323 |
| 106 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.78657195 |
| 107 | termination of RNA polymerase III transcription (GO:0006386) | 2.78657195 |
| 108 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.77719577 |
| 109 | nucleoside monophosphate biosynthetic process (GO:0009124) | 2.77460290 |
| 110 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.76721085 |
| 111 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.76559955 |
| 112 | ribonucleoprotein complex disassembly (GO:0032988) | 2.75954355 |
| 113 | positive regulation of mitochondrial fission (GO:0090141) | 2.73601064 |
| 114 | oxaloacetate metabolic process (GO:0006107) | 2.73058057 |
| 115 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.72814058 |
| 116 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.72411683 |
| 117 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.72411683 |
| 118 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.70518143 |
| 119 | ribonucleoside biosynthetic process (GO:0042455) | 2.67922128 |
| 120 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.67830464 |
| 121 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.67830464 |
| 122 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.67830464 |
| 123 | mitochondrion morphogenesis (GO:0070584) | 2.66625606 |
| 124 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.66220082 |
| 125 | signal peptide processing (GO:0006465) | 2.66182922 |
| 126 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.64396097 |
| 127 | otic vesicle formation (GO:0030916) | 2.62574580 |
| 128 | actin-mediated cell contraction (GO:0070252) | 2.59907738 |
| 129 | intracellular protein transmembrane transport (GO:0065002) | 2.56149525 |
| 130 | formation of translation preinitiation complex (GO:0001731) | 2.55609442 |
| 131 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.55145074 |
| 132 | protein transmembrane transport (GO:0071806) | 2.54562007 |
| 133 | rRNA processing (GO:0006364) | 2.54376462 |
| 134 | regulation of relaxation of muscle (GO:1901077) | 2.50419509 |
| 135 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.49357617 |
| 136 | protein localization to organelle (GO:0033365) | 2.45888404 |
| 137 | rRNA metabolic process (GO:0016072) | 2.42944569 |
| 138 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.41869641 |
| 139 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 10.9682241 |
| 140 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 10.3190355 |
| 141 | ATP synthesis coupled proton transport (GO:0015986) | 10.3190355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.94210429 |
| 2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.16849977 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.72949311 |
| 4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.72879704 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.63965859 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.41118840 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.35907032 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.28558772 |
| 9 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.92418924 |
| 10 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.85015009 |
| 11 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.83666074 |
| 12 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.83160869 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.73786898 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.71148527 |
| 15 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.68285815 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.67396674 |
| 17 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.48833417 |
| 18 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.36025654 |
| 19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.25769518 |
| 20 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.15322864 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.07791984 |
| 22 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.06250256 |
| 23 | * VDR_22108803_ChIP-Seq_LS180_Human | 2.03410282 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.90921980 |
| 25 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89198100 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.88582861 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.84454715 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.83523120 |
| 29 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.81579996 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.80158836 |
| 31 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.77784072 |
| 32 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.75218857 |
| 33 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.73730658 |
| 34 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.73051904 |
| 35 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.72691590 |
| 36 | FUS_26573619_Chip-Seq_HEK293_Human | 1.66994537 |
| 37 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.65579878 |
| 38 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.65094338 |
| 39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.61277509 |
| 40 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.58966115 |
| 41 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.57179434 |
| 42 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.50381709 |
| 43 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.50249438 |
| 44 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.49749400 |
| 45 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.49549838 |
| 46 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.45891369 |
| 47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.44874256 |
| 48 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.41943972 |
| 49 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.38469173 |
| 50 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38345240 |
| 51 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.38050185 |
| 52 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.37596084 |
| 53 | * YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.35477813 |
| 54 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.33996415 |
| 55 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.33586379 |
| 56 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.33163957 |
| 57 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.31656414 |
| 58 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.28445789 |
| 59 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27838914 |
| 60 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.27407877 |
| 61 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.24583482 |
| 62 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.22908242 |
| 63 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.21633548 |
| 64 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.18775561 |
| 65 | * RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.16090932 |
| 66 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.12396864 |
| 67 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.12320562 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12299839 |
| 69 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.08236416 |
| 70 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.07221111 |
| 71 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.06651810 |
| 72 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.04970365 |
| 73 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.01826773 |
| 74 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.01656587 |
| 75 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01406151 |
| 76 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.00730985 |
| 77 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.00287070 |
| 78 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.98546878 |
| 79 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98444783 |
| 80 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.97588255 |
| 81 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.96537557 |
| 82 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.96193591 |
| 83 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.95258029 |
| 84 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.94647758 |
| 85 | EWS_26573619_Chip-Seq_HEK293_Human | 0.94505709 |
| 86 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.94382608 |
| 87 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.92839273 |
| 88 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.92633829 |
| 89 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 0.92392827 |
| 90 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.92191393 |
| 91 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.91968110 |
| 92 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.91419409 |
| 93 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.91188014 |
| 94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.91142500 |
| 95 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.90847330 |
| 96 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.90803457 |
| 97 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.90462209 |
| 98 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89135420 |
| 99 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85316404 |
| 100 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.84968910 |
| 101 | AR_20517297_ChIP-Seq_VCAP_Human | 0.83392919 |
| 102 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.81679865 |
| 103 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.81469808 |
| 104 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.81469808 |
| 105 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.80727223 |
| 106 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.80435985 |
| 107 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.80306538 |
| 108 | * EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.77199336 |
| 109 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.76665378 |
| 110 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.76136544 |
| 111 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.76033073 |
| 112 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.75297271 |
| 113 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.75062989 |
| 114 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.74938057 |
| 115 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.72102615 |
| 116 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.71990556 |
| 117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.71910218 |
| 118 | JUN_21703547_ChIP-Seq_K562_Human | 0.71564804 |
| 119 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70618864 |
| 120 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70293030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.48250792 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.45020023 |
| 3 | MP0006036_abnormal_mitochondrial_physio | 3.99844357 |
| 4 | MP0004215_abnormal_myocardial_fiber | 3.19623435 |
| 5 | MP0003195_calcinosis | 3.04814954 |
| 6 | MP0006035_abnormal_mitochondrial_morpho | 3.02326048 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 2.88298786 |
| 8 | MP0009379_abnormal_foot_pigmentation | 2.82932375 |
| 9 | MP0001529_abnormal_vocalization | 2.81754149 |
| 10 | MP0004036_abnormal_muscle_relaxation | 2.72690298 |
| 11 | MP0004084_abnormal_cardiac_muscle | 2.66433505 |
| 12 | MP0000749_muscle_degeneration | 2.58242010 |
| 13 | MP0005330_cardiomyopathy | 2.54451137 |
| 14 | MP0003880_abnormal_central_pattern | 2.38968668 |
| 15 | MP0004043_abnormal_pH_regulation | 2.37601922 |
| 16 | MP0003186_abnormal_redox_activity | 2.32570589 |
| 17 | MP0006292_abnormal_olfactory_placode | 2.26303302 |
| 18 | MP0000751_myopathy | 2.12048636 |
| 19 | MP0006072_abnormal_retinal_apoptosis | 2.08432020 |
| 20 | MP0004484_altered_response_of | 2.06980373 |
| 21 | MP0004147_increased_porphyrin_level | 2.01077279 |
| 22 | MP0002972_abnormal_cardiac_muscle | 1.98421070 |
| 23 | MP0009697_abnormal_copulation | 1.87882508 |
| 24 | MP0002332_abnormal_exercise_endurance | 1.85598952 |
| 25 | MP0003787_abnormal_imprinting | 1.84447374 |
| 26 | MP0001905_abnormal_dopamine_level | 1.81637305 |
| 27 | MP0005085_abnormal_gallbladder_physiolo | 1.80651624 |
| 28 | MP0004145_abnormal_muscle_electrophysio | 1.77058901 |
| 29 | MP0005535_abnormal_body_temperature | 1.76340142 |
| 30 | MP0008775_abnormal_heart_ventricle | 1.75043490 |
| 31 | MP0005620_abnormal_muscle_contractility | 1.74437901 |
| 32 | MP0005423_abnormal_somatic_nervous | 1.72048833 |
| 33 | MP0004142_abnormal_muscle_tone | 1.69856232 |
| 34 | MP0008875_abnormal_xenobiotic_pharmacok | 1.66177639 |
| 35 | MP0002938_white_spotting | 1.63886649 |
| 36 | MP0004130_abnormal_muscle_cell | 1.63470801 |
| 37 | MP0002638_abnormal_pupillary_reflex | 1.61310658 |
| 38 | MP0003123_paternal_imprinting | 1.57706545 |
| 39 | MP0005332_abnormal_amino_acid | 1.57474374 |
| 40 | MP0006276_abnormal_autonomic_nervous | 1.52935194 |
| 41 | MP0003136_yellow_coat_color | 1.51131958 |
| 42 | MP0008995_early_reproductive_senescence | 1.50088813 |
| 43 | MP0000372_irregular_coat_pigmentation | 1.49297664 |
| 44 | MP0001727_abnormal_embryo_implantation | 1.47405319 |
| 45 | MP0002876_abnormal_thyroid_physiology | 1.47272197 |
| 46 | MP0003137_abnormal_impulse_conducting | 1.47196272 |
| 47 | MP0003011_delayed_dark_adaptation | 1.46882726 |
| 48 | MP0003221_abnormal_cardiomyocyte_apopto | 1.44000983 |
| 49 | MP0001544_abnormal_cardiovascular_syste | 1.40895169 |
| 50 | MP0005385_cardiovascular_system_phenoty | 1.40895169 |
| 51 | MP0002106_abnormal_muscle_physiology | 1.38916152 |
| 52 | MP0005266_abnormal_metabolism | 1.36700981 |
| 53 | MP0004270_analgesia | 1.36564163 |
| 54 | MP0005171_absent_coat_pigmentation | 1.35799807 |
| 55 | MP0001486_abnormal_startle_reflex | 1.34776898 |
| 56 | MP0002734_abnormal_mechanical_nocicepti | 1.33778612 |
| 57 | MP0005084_abnormal_gallbladder_morpholo | 1.32660171 |
| 58 | MP0000013_abnormal_adipose_tissue | 1.28279370 |
| 59 | MP0002139_abnormal_hepatobiliary_system | 1.28191312 |
| 60 | MP0005360_urolithiasis | 1.26946051 |
| 61 | MP0006138_congestive_heart_failure | 1.26872296 |
| 62 | MP0005379_endocrine/exocrine_gland_phen | 1.26522874 |
| 63 | MP0005636_abnormal_mineral_homeostasis | 1.24969656 |
| 64 | MP0004085_abnormal_heartbeat | 1.23503257 |
| 65 | MP0002163_abnormal_gland_morphology | 1.22572569 |
| 66 | MP0003635_abnormal_synaptic_transmissio | 1.22083401 |
| 67 | MP0005408_hypopigmentation | 1.21032668 |
| 68 | MP0005369_muscle_phenotype | 1.17337456 |
| 69 | MP0001764_abnormal_homeostasis | 1.17011956 |
| 70 | MP0000230_abnormal_systemic_arterial | 1.14955375 |
| 71 | MP0004957_abnormal_blastocyst_morpholog | 1.11744161 |
| 72 | MP0008877_abnormal_DNA_methylation | 1.11639928 |
| 73 | MP0005165_increased_susceptibility_to | 1.11563698 |
| 74 | MP0001440_abnormal_grooming_behavior | 1.11289908 |
| 75 | MP0004087_abnormal_muscle_fiber | 1.10193659 |
| 76 | MP0002736_abnormal_nociception_after | 1.09886337 |
| 77 | MP0005551_abnormal_eye_electrophysiolog | 1.08372694 |
| 78 | MP0004742_abnormal_vestibular_system | 1.07161457 |
| 79 | MP0000750_abnormal_muscle_regeneration | 1.07004938 |
| 80 | MP0004924_abnormal_behavior | 1.05604737 |
| 81 | MP0005386_behavior/neurological_phenoty | 1.05604737 |
| 82 | MP0010386_abnormal_urinary_bladder | 1.05117333 |
| 83 | MP0002127_abnormal_cardiovascular_syste | 1.04642811 |
| 84 | MP0003950_abnormal_plasma_membrane | 1.04560433 |
| 85 | MP0002971_abnormal_brown_adipose | 1.02986731 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 1.02098894 |
| 87 | MP0005253_abnormal_eye_physiology | 1.01940121 |
| 88 | MP0003315_abnormal_perineum_morphology | 1.01937411 |
| 89 | MP0005365_abnormal_bile_salt | 1.01805138 |
| 90 | MP0002572_abnormal_emotion/affect_behav | 1.01141737 |
| 91 | MP0002067_abnormal_sensory_capabilities | 1.01060558 |
| 92 | MP0001970_abnormal_pain_threshold | 1.00375002 |
| 93 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.00282520 |
| 94 | MP0003890_abnormal_embryonic-extraembry | 0.99881824 |
| 95 | MP0005376_homeostasis/metabolism_phenot | 0.97975751 |
| 96 | MP0002160_abnormal_reproductive_system | 0.96976137 |
| 97 | MP0003121_genomic_imprinting | 0.96687737 |
| 98 | MP0003941_abnormal_skin_development | 0.96687109 |
| 99 | MP0002184_abnormal_innervation | 0.96683550 |
| 100 | MP0008058_abnormal_DNA_repair | 0.96179399 |
| 101 | MP0009046_muscle_twitch | 0.96154996 |
| 102 | MP0003724_increased_susceptibility_to | 0.95373473 |
| 103 | MP0008789_abnormal_olfactory_epithelium | 0.93112649 |
| 104 | MP0002272_abnormal_nervous_system | 0.92762205 |
| 105 | MP0002090_abnormal_vision | 0.92230803 |
| 106 | MP0001188_hyperpigmentation | 0.90395491 |
| 107 | MP0004885_abnormal_endolymph | 0.89303213 |
| 108 | MP0002557_abnormal_social/conspecific_i | 0.88902267 |
| 109 | MP0002063_abnormal_learning/memory/cond | 0.88847514 |
| 110 | MP0005646_abnormal_pituitary_gland | 0.88679484 |
| 111 | MP0009745_abnormal_behavioral_response | 0.88095558 |
| 112 | MP0000747_muscle_weakness | 0.87783075 |
| 113 | MP0001968_abnormal_touch/_nociception | 0.87055449 |
| 114 | MP0003718_maternal_effect | 0.83783483 |
| 115 | MP0005670_abnormal_white_adipose | 0.83762512 |
| 116 | MP0001293_anophthalmia | 0.82360914 |
| 117 | MP0004859_abnormal_synaptic_plasticity | 0.82298503 |
| 118 | MP0001501_abnormal_sleep_pattern | 0.82232664 |
| 119 | MP0002822_catalepsy | 0.81409655 |
| 120 | MP0000759_abnormal_skeletal_muscle | 0.81224965 |
| 121 | MP0005451_abnormal_body_composition | 0.80566616 |
| 122 | MP0008004_abnormal_stomach_pH | 0.79909030 |
| 123 | MP0000343_altered_response_to | 0.79873474 |
| 124 | MP0001984_abnormal_olfaction | 0.79102451 |
| 125 | MP0000778_abnormal_nervous_system | 0.78239689 |
| 126 | MP0002752_abnormal_somatic_nervous | 0.78197118 |
| 127 | MP0000955_abnormal_spinal_cord | 0.77956431 |
| 128 | MP0002269_muscular_atrophy | 0.77818554 |
| 129 | MP0002066_abnormal_motor_capabilities/c | 0.76213978 |
| 130 | MP0005319_abnormal_enzyme/_coenzyme | 0.76142716 |
| 131 | MP0002277_abnormal_respiratory_mucosa | 0.74619372 |
| 132 | MP0002064_seizures | 0.72375305 |
| 133 | MP0002078_abnormal_glucose_homeostasis | 0.71855388 |
| 134 | MP0001485_abnormal_pinna_reflex | 0.71786841 |
| 135 | MP0002733_abnormal_thermal_nociception | 0.70709252 |
| 136 | MP0008872_abnormal_physiological_respon | 0.69558061 |
| 137 | MP0009643_abnormal_urine_homeostasis | 0.68335129 |
| 138 | MP0002118_abnormal_lipid_homeostasis | 0.66851725 |
| 139 | MP0000358_abnormal_cell_content/ | 0.66406649 |
| 140 | MP0010630_abnormal_cardiac_muscle | 0.62929602 |
| 141 | MP0002735_abnormal_chemical_nociception | 0.62732965 |
| 142 | MP0003567_abnormal_fetal_cardiomyocyte | 0.62649775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 7.96957735 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 7.41407276 |
| 3 | Acute encephalopathy (HP:0006846) | 6.78644693 |
| 4 | Progressive macrocephaly (HP:0004481) | 6.77497706 |
| 5 | Mitochondrial inheritance (HP:0001427) | 6.47980429 |
| 6 | Increased CSF lactate (HP:0002490) | 5.80012876 |
| 7 | Hepatic necrosis (HP:0002605) | 5.58934209 |
| 8 | Hepatocellular necrosis (HP:0001404) | 5.47878642 |
| 9 | Cerebral edema (HP:0002181) | 5.38246923 |
| 10 | Increased serum pyruvate (HP:0003542) | 4.79714713 |
| 11 | Abnormality of glycolysis (HP:0004366) | 4.79714713 |
| 12 | Increased hepatocellular lipid droplets (HP:0006565) | 4.67070537 |
| 13 | Lipid accumulation in hepatocytes (HP:0006561) | 4.60264391 |
| 14 | Exercise intolerance (HP:0003546) | 4.27210158 |
| 15 | Lactic acidosis (HP:0003128) | 4.26796838 |
| 16 | Respiratory failure (HP:0002878) | 4.16389587 |
| 17 | Increased intramyocellular lipid droplets (HP:0012240) | 4.02849070 |
| 18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.02283488 |
| 19 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.02283488 |
| 20 | Optic disc pallor (HP:0000543) | 3.94963848 |
| 21 | Renal Fanconi syndrome (HP:0001994) | 3.85978047 |
| 22 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.83979340 |
| 23 | Increased muscle lipid content (HP:0009058) | 3.82693598 |
| 24 | Leukodystrophy (HP:0002415) | 3.69870890 |
| 25 | Increased serum lactate (HP:0002151) | 3.61890329 |
| 26 | 3-Methylglutaconic aciduria (HP:0003535) | 3.48564132 |
| 27 | Nemaline bodies (HP:0003798) | 3.43058531 |
| 28 | Muscle fiber inclusion bodies (HP:0100299) | 3.42159532 |
| 29 | Myokymia (HP:0002411) | 3.40866054 |
| 30 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.34538450 |
| 31 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.27705456 |
| 32 | Pallor (HP:0000980) | 3.20361596 |
| 33 | Lethargy (HP:0001254) | 3.09713460 |
| 34 | Abnormality of urine glucose concentration (HP:0011016) | 3.03983245 |
| 35 | Glycosuria (HP:0003076) | 3.03983245 |
| 36 | Generalized aminoaciduria (HP:0002909) | 2.96236544 |
| 37 | Dicarboxylic aciduria (HP:0003215) | 2.94126862 |
| 38 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.94126862 |
| 39 | Exertional dyspnea (HP:0002875) | 2.92674838 |
| 40 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.89734022 |
| 41 | Abnormality of alanine metabolism (HP:0010916) | 2.89734022 |
| 42 | Hyperalaninemia (HP:0003348) | 2.89734022 |
| 43 | Neuroendocrine neoplasm (HP:0100634) | 2.88821866 |
| 44 | Respiratory difficulties (HP:0002880) | 2.88260290 |
| 45 | X-linked dominant inheritance (HP:0001423) | 2.82470836 |
| 46 | Palpitations (HP:0001962) | 2.80517535 |
| 47 | Pheochromocytoma (HP:0002666) | 2.79871390 |
| 48 | Hypoglycemic coma (HP:0001325) | 2.79212209 |
| 49 | Conjunctival hamartoma (HP:0100780) | 2.77793569 |
| 50 | Abnormality of renal resorption (HP:0011038) | 2.64015981 |
| 51 | CNS demyelination (HP:0007305) | 2.63277852 |
| 52 | Calf muscle hypertrophy (HP:0008981) | 2.62978059 |
| 53 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.62936902 |
| 54 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.51312871 |
| 55 | Rhabdomyolysis (HP:0003201) | 2.50657471 |
| 56 | Myoglobinuria (HP:0002913) | 2.50073840 |
| 57 | Methylmalonic aciduria (HP:0012120) | 2.47373095 |
| 58 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.44379378 |
| 59 | Vomiting (HP:0002013) | 2.43909286 |
| 60 | Bundle branch block (HP:0011710) | 2.31168749 |
| 61 | Ketoacidosis (HP:0001993) | 2.31076924 |
| 62 | Abnormal number of erythroid precursors (HP:0012131) | 2.30998508 |
| 63 | Nausea (HP:0002018) | 2.30290104 |
| 64 | Microvesicular hepatic steatosis (HP:0001414) | 2.28695316 |
| 65 | Exercise-induced muscle cramps (HP:0003710) | 2.28386581 |
| 66 | Hyperphosphaturia (HP:0003109) | 2.21699122 |
| 67 | Methylmalonic acidemia (HP:0002912) | 2.21339271 |
| 68 | Proximal tubulopathy (HP:0000114) | 2.20918040 |
| 69 | Sudden death (HP:0001699) | 2.18196287 |
| 70 | Ragged-red muscle fibers (HP:0003200) | 2.17758634 |
| 71 | Myotonia (HP:0002486) | 2.15548836 |
| 72 | Septo-optic dysplasia (HP:0100842) | 2.13378491 |
| 73 | Exercise-induced myalgia (HP:0003738) | 2.12409008 |
| 74 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.10921582 |
| 75 | Esophageal neoplasm (HP:0100751) | 2.06065826 |
| 76 | Neoplasm of head and neck (HP:0012288) | 2.06065826 |
| 77 | Emotional lability (HP:0000712) | 2.04847588 |
| 78 | Renal cortical cysts (HP:0000803) | 2.04348777 |
| 79 | Gliosis (HP:0002171) | 2.04079604 |
| 80 | Rimmed vacuoles (HP:0003805) | 1.89639453 |
| 81 | Neoplasm of the adrenal gland (HP:0100631) | 1.88355096 |
| 82 | Ventricular tachycardia (HP:0004756) | 1.88093695 |
| 83 | Ketosis (HP:0001946) | 1.87299880 |
| 84 | Cerebral hemorrhage (HP:0001342) | 1.85594064 |
| 85 | Abnormality of placental membranes (HP:0011409) | 1.84393967 |
| 86 | Amniotic constriction ring (HP:0009775) | 1.84393967 |
| 87 | * Metabolic acidosis (HP:0001942) | 1.83944110 |
| 88 | EMG: myopathic abnormalities (HP:0003458) | 1.83623015 |
| 89 | Type 1 muscle fiber predominance (HP:0003803) | 1.83403532 |
| 90 | Stenosis of the external auditory canal (HP:0000402) | 1.83364413 |
| 91 | Abnormal urine phosphate concentration (HP:0012599) | 1.80134259 |
| 92 | Blindness (HP:0000618) | 1.79434289 |
| 93 | Renal tubular dysfunction (HP:0000124) | 1.79265891 |
| 94 | Parakeratosis (HP:0001036) | 1.79196318 |
| 95 | Abnormality of methionine metabolism (HP:0010901) | 1.78339349 |
| 96 | Absence seizures (HP:0002121) | 1.75261584 |
| 97 | Aplastic anemia (HP:0001915) | 1.74669703 |
| 98 | Medial flaring of the eyebrow (HP:0010747) | 1.74286681 |
| 99 | Hypothermia (HP:0002045) | 1.72987097 |
| 100 | Abnormal pupillary function (HP:0007686) | 1.71261983 |
| 101 | Hyperammonemia (HP:0001987) | 1.70732908 |
| 102 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.70589336 |
| 103 | Abnormality of the calf musculature (HP:0001430) | 1.69283599 |
| 104 | Lipoatrophy (HP:0100578) | 1.69169556 |
| 105 | Maternal diabetes (HP:0009800) | 1.69031980 |
| 106 | Abnormality of serum amino acid levels (HP:0003112) | 1.67093434 |
| 107 | Absent septum pellucidum (HP:0001331) | 1.66319015 |
| 108 | Congenital, generalized hypertrichosis (HP:0004540) | 1.66015712 |
| 109 | Hyperglycinuria (HP:0003108) | 1.65695658 |
| 110 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.64978713 |
| 111 | Primary atrial arrhythmia (HP:0001692) | 1.62911152 |
| 112 | Hyperventilation (HP:0002883) | 1.62648764 |
| 113 | Megaloblastic anemia (HP:0001889) | 1.62240059 |
| 114 | Abnormal hemoglobin (HP:0011902) | 1.61771025 |
| 115 | Atrial fibrillation (HP:0005110) | 1.60879688 |
| 116 | Macrocytic anemia (HP:0001972) | 1.60153841 |
| 117 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.59956900 |
| 118 | Hypoplastic left heart (HP:0004383) | 1.59169271 |
| 119 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.58850767 |
| 120 | Dilated cardiomyopathy (HP:0001644) | 1.58410307 |
| 121 | Left ventricular hypertrophy (HP:0001712) | 1.56994712 |
| 122 | Depressed nasal ridge (HP:0000457) | 1.56886531 |
| 123 | Tinnitus (HP:0000360) | 1.56695284 |
| 124 | Heart block (HP:0012722) | 1.56189995 |
| 125 | Confusion (HP:0001289) | 1.55622416 |
| 126 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.55525579 |
| 127 | Multiple enchondromatosis (HP:0005701) | 1.54400720 |
| 128 | Supraventricular arrhythmia (HP:0005115) | 1.54140016 |
| 129 | Distal arthrogryposis (HP:0005684) | 1.52680859 |
| 130 | Hyperglycinemia (HP:0002154) | 1.52626869 |
| 131 | Molar tooth sign on MRI (HP:0002419) | 1.52506104 |
| 132 | Abnormality of midbrain morphology (HP:0002418) | 1.52506104 |
| 133 | Muscle stiffness (HP:0003552) | 1.51008009 |
| 134 | Supraventricular tachycardia (HP:0004755) | 1.50141535 |
| 135 | Reticulocytopenia (HP:0001896) | 1.49253346 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.58931789 |
| 2 | MYLK | 3.39573819 |
| 3 | NME1 | 3.38755895 |
| 4 | VRK2 | 3.03976847 |
| 5 | OBSCN | 2.94510643 |
| 6 | MAP3K12 | 2.93130220 |
| 7 | STK16 | 2.91777868 |
| 8 | BCKDK | 2.64979337 |
| 9 | MST4 | 2.63356660 |
| 10 | PDK4 | 2.49121175 |
| 11 | PDK3 | 2.49121175 |
| 12 | PBK | 2.38619837 |
| 13 | GRK7 | 2.26753308 |
| 14 | MUSK | 2.17733171 |
| 15 | PDK2 | 1.99509013 |
| 16 | CASK | 1.97981113 |
| 17 | CDC7 | 1.86714962 |
| 18 | EIF2AK3 | 1.86654727 |
| 19 | EIF2AK1 | 1.77618042 |
| 20 | ARAF | 1.76103110 |
| 21 | WNK4 | 1.74076766 |
| 22 | STK39 | 1.72243150 |
| 23 | VRK1 | 1.68117705 |
| 24 | STK24 | 1.60423930 |
| 25 | MAP2K7 | 1.60232163 |
| 26 | BMPR2 | 1.56123669 |
| 27 | OXSR1 | 1.52136960 |
| 28 | MARK1 | 1.40275481 |
| 29 | PLK2 | 1.36226051 |
| 30 | PNCK | 1.35273973 |
| 31 | PINK1 | 1.25097170 |
| 32 | ZAK | 1.24014557 |
| 33 | WEE1 | 1.23750353 |
| 34 | ADRBK2 | 1.20876154 |
| 35 | DMPK | 1.19740915 |
| 36 | GRK5 | 1.19015976 |
| 37 | WNK3 | 1.15942114 |
| 38 | NTRK3 | 1.14905455 |
| 39 | TLK1 | 1.14837271 |
| 40 | BCR | 1.11214895 |
| 41 | ABL2 | 1.10237016 |
| 42 | PIK3CG | 1.05858874 |
| 43 | RIPK4 | 0.99161744 |
| 44 | STK38L | 0.99000409 |
| 45 | UHMK1 | 0.97372768 |
| 46 | BMPR1B | 0.97334993 |
| 47 | BUB1 | 0.97054663 |
| 48 | TNIK | 0.96896697 |
| 49 | RPS6KB2 | 0.95748534 |
| 50 | LIMK1 | 0.94570691 |
| 51 | MINK1 | 0.92662675 |
| 52 | MAP3K4 | 0.92383928 |
| 53 | PIK3CA | 0.92199201 |
| 54 | DYRK3 | 0.91755455 |
| 55 | INSRR | 0.91230196 |
| 56 | SRPK1 | 0.88945196 |
| 57 | CDK19 | 0.88569834 |
| 58 | CAMK2A | 0.85943087 |
| 59 | CCNB1 | 0.85566368 |
| 60 | PLK4 | 0.84945648 |
| 61 | CAMK2D | 0.82674579 |
| 62 | PRKCE | 0.82109869 |
| 63 | CSNK1E | 0.81620382 |
| 64 | KDR | 0.81408426 |
| 65 | PIM2 | 0.81038291 |
| 66 | PHKG2 | 0.80901875 |
| 67 | PHKG1 | 0.80901875 |
| 68 | NEK2 | 0.80828408 |
| 69 | TIE1 | 0.79951811 |
| 70 | PASK | 0.77923295 |
| 71 | CAMK2G | 0.73213135 |
| 72 | ILK | 0.72895108 |
| 73 | MKNK2 | 0.71385310 |
| 74 | ACVR1B | 0.71302983 |
| 75 | MAP2K4 | 0.71222840 |
| 76 | CDK3 | 0.71209720 |
| 77 | TAF1 | 0.70382707 |
| 78 | ADRBK1 | 0.69629753 |
| 79 | LATS2 | 0.69088131 |
| 80 | BRAF | 0.66816770 |
| 81 | CAMK1 | 0.66174831 |
| 82 | TTK | 0.65072727 |
| 83 | AURKB | 0.64925283 |
| 84 | FRK | 0.64751132 |
| 85 | MAP3K9 | 0.64484646 |
| 86 | EIF2AK2 | 0.63837269 |
| 87 | CAMK2B | 0.63771515 |
| 88 | AKT3 | 0.63556043 |
| 89 | MST1R | 0.62633457 |
| 90 | PRKACA | 0.60845905 |
| 91 | LRRK2 | 0.60164816 |
| 92 | DYRK2 | 0.58223430 |
| 93 | MAPK12 | 0.58194521 |
| 94 | PRKG1 | 0.57869284 |
| 95 | MAP4K2 | 0.56235547 |
| 96 | NEK1 | 0.55640442 |
| 97 | PRKACB | 0.54061726 |
| 98 | EPHA4 | 0.53993677 |
| 99 | PLK1 | 0.53517811 |
| 100 | MAPK13 | 0.53390398 |
| 101 | CSNK2A1 | 0.52990022 |
| 102 | TEC | 0.51936565 |
| 103 | SCYL2 | 0.51605578 |
| 104 | PRKCG | 0.50177199 |
| 105 | ERBB3 | 0.49531592 |
| 106 | TTN | 0.48322972 |
| 107 | NTRK2 | 0.47740112 |
| 108 | IRAK3 | 0.46736198 |
| 109 | TSSK6 | 0.45055524 |
| 110 | DAPK1 | 0.44993227 |
| 111 | GRK1 | 0.44963453 |
| 112 | PAK3 | 0.44510695 |
| 113 | MAPKAPK5 | 0.42664872 |
| 114 | DAPK3 | 0.42357589 |
| 115 | CDK8 | 0.41096762 |
| 116 | CAMKK2 | 0.40882069 |
| 117 | CSNK2A2 | 0.39966026 |
| 118 | BRSK2 | 0.37219997 |
| 119 | ERBB4 | 0.36221141 |
| 120 | YES1 | 0.35964742 |
| 121 | PLK3 | 0.35680554 |
| 122 | MAPK15 | 0.34677383 |
| 123 | FGR | 0.34163545 |
| 124 | PRKCQ | 0.32749875 |
| 125 | MKNK1 | 0.32196637 |
| 126 | PTK2B | 0.31893468 |
| 127 | MAPK4 | 0.28313437 |
| 128 | NUAK1 | 0.27872872 |
| 129 | AURKA | 0.27821553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Oxidative phosphorylation_Homo sapiens_hsa00190 | 6.09039085 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 5.28466310 |
| 3 | Alzheimers disease_Homo sapiens_hsa05010 | 3.95168195 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.76783572 |
| 5 | Huntingtons disease_Homo sapiens_hsa05016 | 3.70762383 |
| 6 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.44425949 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 3.18287789 |
| 8 | Ribosome_Homo sapiens_hsa03010 | 2.87715070 |
| 9 | * Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.67460808 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.49725942 |
| 11 | Protein export_Homo sapiens_hsa03060 | 2.47116345 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.13633398 |
| 13 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.03346763 |
| 14 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.94342115 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.89476083 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.86853309 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.80680956 |
| 18 | RNA polymerase_Homo sapiens_hsa03020 | 1.77030028 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.73344617 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.63614818 |
| 21 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.52085876 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.51351737 |
| 23 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.39709682 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.23082260 |
| 25 | Peroxisome_Homo sapiens_hsa04146 | 1.15031632 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.12340330 |
| 27 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.98887337 |
| 28 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.98265160 |
| 29 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.97854452 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.97397769 |
| 31 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.94414812 |
| 32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.94048294 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.93006689 |
| 34 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.87169630 |
| 35 | Asthma_Homo sapiens_hsa05310 | 0.85202857 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84491072 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.84039417 |
| 38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.83273431 |
| 39 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.83085019 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.81549864 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.79368283 |
| 42 | RNA transport_Homo sapiens_hsa03013 | 0.75184620 |
| 43 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73823340 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71831192 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68422998 |
| 46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68325948 |
| 47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.66927495 |
| 48 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63862535 |
| 49 | Purine metabolism_Homo sapiens_hsa00230 | 0.62708703 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62067011 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61405043 |
| 52 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.60205366 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.58041917 |
| 54 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56251269 |
| 55 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55574389 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55056776 |
| 57 | Morphine addiction_Homo sapiens_hsa05032 | 0.53210951 |
| 58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52997221 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52979213 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.52503788 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51848300 |
| 62 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51784759 |
| 63 | Mineral absorption_Homo sapiens_hsa04978 | 0.51486309 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.50798939 |
| 65 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.50375836 |
| 66 | Insulin secretion_Homo sapiens_hsa04911 | 0.48548428 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.48215203 |
| 68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47778882 |
| 69 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.46784281 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45042543 |
| 71 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45002414 |
| 72 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.44390614 |
| 73 | Circadian entrainment_Homo sapiens_hsa04713 | 0.44104069 |
| 74 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43903650 |
| 75 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.43388209 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.43305678 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.40097783 |
| 78 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.38192054 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.37079366 |
| 80 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.36937065 |
| 81 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.36088478 |
| 82 | RNA degradation_Homo sapiens_hsa03018 | 0.35353368 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.34098711 |
| 84 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.34062614 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.33593266 |
| 86 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31637759 |
| 87 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.31617891 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.31419575 |
| 89 | Basal transcription factors_Homo sapiens_hsa03022 | 0.30660041 |
| 90 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30232060 |
| 91 | Nicotine addiction_Homo sapiens_hsa05033 | 0.30219961 |
| 92 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.29552732 |
| 93 | Homologous recombination_Homo sapiens_hsa03440 | 0.29189508 |
| 94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.28499097 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.27822659 |
| 96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.27721893 |
| 97 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.27546633 |
| 98 | Retinol metabolism_Homo sapiens_hsa00830 | 0.24483355 |
| 99 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.24209379 |
| 100 | Spliceosome_Homo sapiens_hsa03040 | 0.24148598 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23387821 |
| 102 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.23132117 |
| 103 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.22593949 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.22069889 |
| 105 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.21696671 |
| 106 | Taste transduction_Homo sapiens_hsa04742 | 0.20414120 |
| 107 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.19868129 |
| 108 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.19686694 |
| 109 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.18823662 |
| 110 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.17990477 |
| 111 | Mismatch repair_Homo sapiens_hsa03430 | 0.17989401 |
| 112 | Renin secretion_Homo sapiens_hsa04924 | 0.17883176 |
| 113 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.17270866 |
| 114 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.16500817 |
| 115 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.15374313 |
| 116 | Sulfur relay system_Homo sapiens_hsa04122 | 0.14528720 |
| 117 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.14398382 |
| 118 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.13963343 |
| 119 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.12158364 |
| 120 | GABAergic synapse_Homo sapiens_hsa04727 | 0.11543001 |
| 121 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.09599549 |
| 122 | DNA replication_Homo sapiens_hsa03030 | 0.07021231 |
| 123 | Phototransduction_Homo sapiens_hsa04744 | 0.06707924 |

